Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5381056 | 0.78 | ALDH1A1 (0.42) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL5381060 | 0.78 | ALDH1A1 (0.42) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL8787277 | 0.73 | KMT2A (0.44) | ALDH1A1GAAKMT2ANPC1PKM | |
| SCHEMBL6848487 | 0.71 | PKM (0.33) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL6848488 | 0.71 | PKM (0.33) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL6294806 | 0.71 | POLB (0.33) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL764718 | 0.71 | ALDH1A1 (0.36) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL22381039 | 0.70 | SMN1; SMN2 (0.47) | CYP1A2ALDH1A1CYP2C19MEN1KMT2A | |
| SCHEMBL5369754 | 0.69 | ALDH1A1 (0.44) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 | |
| SCHEMBL5369758 | 0.69 | ALDH1A1 (0.44) | CYP1A2CYP2D6ALDH1A1GAACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142820-A1 | Pyrazolylarylalkines | VENTURE LENDING & LEASING IX, INC. | 2004-07-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142820-A1 | Pyrazolylarylalkines | CBR3, PPOX, ALK | CYP1A2 7/4885CYP2D6 62/4885ALDH1A1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.